Optovue’s AngioVue Imaging System Receives FDA Clearance

Febraury 12, 2016

“Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced FDA clearance and immediate U.S. commercial availability of the AngioVue™ Imaging System, a groundbreaking technology that provides a non-invasive way to visualize abnormal blood vessels in the retina to help physicians determine an appropriate course of treatment.”

Read more here!: http://www.optovue.com/news/optovues-angiovue-imaging-system-receives-fda-clearance/